vs
MARKETWISE, INC.（MKTW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
MARKETWISE, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$83.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 2.3%，领先381.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -14.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -12.5%）
MarketWise Inc.是一家领先的投资研究、金融市场数据及财富管理教育解决方案提供商，服务覆盖北美、欧洲及亚太地区的个人与机构投资者，核心产品包括实用市场洞察、投资组合分析工具及多资产类别专项研究内容。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MKTW vs RIGL — 直观对比
营收规模更大
MKTW
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出35.6%
-14.4%
净利率更高
RIGL
高出381.7%
2.3%
两年增速更快
RIGL
近两年复合增速
-12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.4M | $69.8M |
| 净利润 | $1.9M | $268.1M |
| 毛利率 | 87.0% | 91.5% |
| 营业利润率 | 15.8% | 33.2% |
| 净利率 | 2.3% | 384.0% |
| 营收同比 | -14.4% | 21.2% |
| 净利润同比 | -9.8% | 1769.2% |
| 每股收益（稀释后） | $0.79 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MKTWRIGL
| Q4 25 | $83.4M | $69.8M | ||
| Q3 25 | $81.3M | $69.5M | ||
| Q2 25 | $80.0M | $101.7M | ||
| Q1 25 | $83.5M | $53.3M | ||
| Q4 24 | $97.5M | $57.6M | ||
| Q3 24 | $97.2M | $55.3M | ||
| Q2 24 | $105.0M | $36.8M | ||
| Q1 24 | $109.0M | $29.5M |
净利润MKTWRIGL
| Q4 25 | $1.9M | $268.1M | ||
| Q3 25 | $1.5M | $27.9M | ||
| Q2 25 | $1.3M | $59.6M | ||
| Q1 25 | $890.0K | $11.4M | ||
| Q4 24 | $2.1M | $14.3M | ||
| Q3 24 | $1.7M | $12.4M | ||
| Q2 24 | $1.5M | $-1.0M | ||
| Q1 24 | $1.7M | $-8.2M |
毛利率MKTWRIGL
| Q4 25 | 87.0% | 91.5% | ||
| Q3 25 | 87.0% | 93.2% | ||
| Q2 25 | 86.3% | 95.6% | ||
| Q1 25 | 85.7% | 91.7% | ||
| Q4 24 | 88.7% | 89.9% | ||
| Q3 24 | 86.7% | 85.5% | ||
| Q2 24 | 87.3% | 92.4% | ||
| Q1 24 | 87.7% | 93.1% |
营业利润率MKTWRIGL
| Q4 25 | 15.8% | 33.2% | ||
| Q3 25 | 21.9% | 40.9% | ||
| Q2 25 | 18.5% | 60.1% | ||
| Q1 25 | 20.1% | 23.9% | ||
| Q4 24 | 24.8% | 28.9% | ||
| Q3 24 | 22.5% | 25.4% | ||
| Q2 24 | 20.3% | 1.2% | ||
| Q1 24 | 19.8% | -23.6% |
净利率MKTWRIGL
| Q4 25 | 2.3% | 384.0% | ||
| Q3 25 | 1.9% | 40.2% | ||
| Q2 25 | 1.6% | 58.6% | ||
| Q1 25 | 1.1% | 21.5% | ||
| Q4 24 | 2.2% | 24.9% | ||
| Q3 24 | 1.8% | 22.5% | ||
| Q2 24 | 1.5% | -2.8% | ||
| Q1 24 | 1.5% | -27.9% |
每股收益（稀释后）MKTWRIGL
| Q4 25 | $0.79 | $14.11 | ||
| Q3 25 | $0.58 | $1.46 | ||
| Q2 25 | $0.53 | $3.28 | ||
| Q1 25 | $0.41 | $0.63 | ||
| Q4 24 | $1.06 | $0.82 | ||
| Q3 24 | $0.87 | $0.70 | ||
| Q2 24 | $0.80 | $-0.06 | ||
| Q1 24 | $0.85 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $70.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-11.7M | $391.5M |
| 总资产 | $218.4M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MKTWRIGL
| Q4 25 | $70.1M | $155.0M | ||
| Q3 25 | $50.5M | $137.1M | ||
| Q2 25 | $69.1M | $108.4M | ||
| Q1 25 | $79.2M | $77.1M | ||
| Q4 24 | $97.9M | $77.3M | ||
| Q3 24 | $94.1M | $61.1M | ||
| Q2 24 | $109.3M | $49.1M | ||
| Q1 24 | $131.2M | $49.5M |
总债务MKTWRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $707.0K | $60.0M |
股东权益MKTWRIGL
| Q4 25 | $-11.7M | $391.5M | ||
| Q3 25 | $-14.5M | $117.6M | ||
| Q2 25 | $-15.8M | $81.9M | ||
| Q1 25 | $-15.8M | $18.6M | ||
| Q4 24 | $-12.5M | $3.3M | ||
| Q3 24 | $-19.5M | $-14.6M | ||
| Q2 24 | $-23.7M | $-29.9M | ||
| Q1 24 | $-9.4M | $-31.7M |
总资产MKTWRIGL
| Q4 25 | $218.4M | $513.6M | ||
| Q3 25 | $201.7M | $242.5M | ||
| Q2 25 | $211.8M | $206.7M | ||
| Q1 25 | $239.6M | $176.0M | ||
| Q4 24 | $259.5M | $164.0M | ||
| Q3 24 | $278.4M | $139.4M | ||
| Q2 24 | $315.3M | $128.4M | ||
| Q1 24 | $359.3M | $126.5M |
负债/权益比MKTWRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $45.6M | — |
| 自由现金流率自由现金流/营收 | 54.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | 23.84× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $67.1M | — |
8季度趋势，按日历期对齐
经营现金流MKTWRIGL
| Q4 25 | $46.0M | $22.0M | ||
| Q3 25 | $2.2M | $24.0M | ||
| Q2 25 | $17.8M | $30.5M | ||
| Q1 25 | $1.7M | $-893.0K | ||
| Q4 24 | $-22.1M | $14.5M | ||
| Q3 24 | $-5.8M | $21.7M | ||
| Q2 24 | $-3.8M | $302.0K | ||
| Q1 24 | $-18.5M | $-5.0M |
自由现金流MKTWRIGL
| Q4 25 | $45.6M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $17.7M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $-22.3M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | — | — |
自由现金流率MKTWRIGL
| Q4 25 | 54.6% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 22.2% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | -22.9% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | — | — |
资本支出强度MKTWRIGL
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率MKTWRIGL
| Q4 25 | 23.84× | 0.08× | ||
| Q3 25 | 1.44× | 0.86× | ||
| Q2 25 | 13.76× | 0.51× | ||
| Q1 25 | 1.95× | -0.08× | ||
| Q4 24 | -10.36× | 1.01× | ||
| Q3 24 | -3.39× | 1.75× | ||
| Q2 24 | -2.46× | — | ||
| Q1 24 | -11.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
